EVIDENCE: TYPE 2 DIABETES

Type 2 Diabetes

Our behaviour change intervention for Type 2 Diabetes saves £117.52 per patient, per year in demedication alone.
Learn More
Trusted by workplace, insurance, local authority, primary care and hospitals
NHS Kernow CCG
NHS Southampton City CCG
Aviva Logo
Novo Nordisk logo
SwissRe Logo
BSP logo
DigitalHealth London logo

Industry-leading outcomes

95%
Activation from referral
52%
Complete the program
1.2%
Average HbA1c reduction
54%
Reduce or eliminate medication
71%
Retention at 12 months

Use cases

01

Remission platform

Support remission of type 2 diabetes and improvements in weight, blood glucose and medication dependency.

02

Structured education

Use as a structured education and behaviour change platform to support improved self-management of type 2 diabetes.

03

Remote monitoring

Use to remotely monitor patients and use the data to inform treatment planning and clinical appointments.

RESEARCH

Published evidence

CLINICAL COST SAVINGS

Reduce your spend on Type 2 Diabetes medications by £117.57 per patient, per year

For every 3,000 patients, an NHS CCG can save £956,000 over 5 years in reduced HbA1c and reduced medication, with an average saving of £117.57 per patient, per year in reduced medication.

Signposting takes between 1 and 4 minutes with an average of 26% of participants achieving type 2 diabetes remission.

Benefits for patients

Co-designed with 100,000 people.

Increased adherence 🌟

Up to 100% referral

Engage people in their health and wellbeing with personalised care tailored to health and preferences

Multi-cultural content

Designed to engage seldom heard and heard to reach communities

87% retention

Industry-leading long-term retention

Available in 6 languages

Available in a range of languages to engage a diverse and varied population

Improved health outcomes in 12 weeks🥳

Improvements in perceived stress

23% reduction in stress as measured by the Perceived Stress Scale

Improvements in anxiety

32% reduction in anxiety symptoms as measured by the GAD7 scale

Improvements in depression

31% reduction in anxiety symptoms as measured by the PHQ9 scale

Cutting-edge user experience 📲

Easy to use

8.7 in 10 participants says the program is easy to use and understand

Highly accessible

9 in 10 participants says the program is easy to understand

Recommended

9 in 10 participants would recommend the program

Peter Palmer
Patient

"My HbA1c has dropped from 53 (7.0%) to 37 mmol/mol (5.5%) and I’ve lost 19kg. I’m in type 2 remission and never felt fitter. If it wasn’t for the Low Carb Program and the support I received, I wouldn’t be where I am today.”

Benefits for clinicians

Providing patient, provider and cost-saving benefits.

Improved efficiency ⚡

Signposted in under 60 seconds

Signpost in as little as a minute using a physical or digital code

Digital training

Full end-to-end digital training and support delivered face-to-face and digitally

Co-design and signposting

Support your population with bespoke resources and resource signposting

Implementation support 🤝

Full clinical and technical training

Full training delivered to your needs and requirements

Onboarding support

Support for patients and clinicians from start to finish

Around the clock support

Operational support is available 24 hours a day, 7 days a week

Lower costs 💸

Reduced medications

Participants reduce the number of drugs used for depression and anxiety after prolonged use

Remote monitoring

Monitor progress and arrange appointments

Reduced non-compliance

87% of participants remain engaged at 6 months

“Local professionals and patients should have options to consider for treatment of type 2 diabetes, which this app provides"

Professor Partha Kar
national specialty advisor, Diabetes england
trusted by the NHS

Benefits to NHS

Cost savings

£956,000 per year saving for every 3,000 NHS patients referred into the platform in demedication*

£65-£91m savings

Potential saving if 3,000 patients in each of England's 135 CCGs enrolled into the program

Supporting millions

Reducing medication usage by 61% in the first year

*Economic Impact Evaluation Case Study: Low Carb Program, York Health Economics Consortium

Get in touch

We're always innovating at DDM. If you're interested in collaborating, or just want to stay up-to-date, fill out the form below.

Enquiry type
Thank you! Your enquiry has been received and a member of the team will be in touch shortly.
Oops! Something went wrong while submitting the form.